(UC Newsroom) The Food and Drug Administration today approved daraxonrasib to treat the most common form of pancreatic cancer. It's the first treatment to substantially extend the lives of patients diagnosed with the third-leading cause of cancer death in the U.S.
Dr. Jing Li, a postdoctoral researcher in Dr. Shiyu Xia's lab within the Department of CBE, has been selected as a 2026 Fellow of the Jane Coffin Childs Memorial Fund for Medical Research (JCC Fund).
(The Straits Times) A new laboratory has been launched in Singapore to transform recent breakthroughs in synthetic biology into commercial products from eco-friendly cosmetics to affordable vaccines.
A research university emphasizes entrepreneurial science—and spawns start-ups in fields as varied as genetic medicine, humanoid robotics and carbon-catching materials.
The Healthcare Conference Taipei serves as an international summit connecting academic research with the global health industry, featuring biotech startup showcases and partnerships.
A record number of students and faculty in Berkeley’s College of Chemistry have ties to Africa, and the continent is inspiring their science and career paths.
(NPR) A single infusion of an experimental gene-editing drug appears safe and effective for cutting cholesterol, possibly for life, according to a small early study released Saturday.
Zirun was honored for his research with Professor Markita Landry, entitled 'Single-Molecule Modification of Carbon Nanotubes Through Stochastic Deposition of ssDNA'.
